Evidence map›Paper›PMID 22443930›Full record

ReviewAnnual review of biochemistry2012

Endoplasmic reticulum stress and type 2 diabetes.

Sung Hoon Back, Randal J Kaufman

Abstract readReview
In one paragraph

Review in Annual review of biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 327 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
327citing papers in PubMed, 1 pooled it
22.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

327 citing papers in PubMed, 1 synthesis or guideline pooled it, 599 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Oxidative protein folding and CaCellular and molecular life sciences : CMLS · 2026
    Review
  8. Article
  9. QBP1 Peptide as a Potential Anti-Amyloidogenic Therapy for Type 2 Diabetes: An In Vitro Study.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Lipid Metabolism in Relation to Carbohydrate Metabolism.Advances in experimental medicine and biology · 2026
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. International journal of endocrinology · 2026
    Article
  20. Review

267 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Sung Hoon BackSchool of Biological Sciences, University of Ulsan, Ulsan, Republic of Korea. shback@ulsan.ac.kr
Randal J Kaufman
Sanford Burnham Prebys Medical Discovery Institute · USUniversity of Ulsan · KR

Funding

TRANSGENIC MODELS FOR THE STUDY OF FACTOR V FUNCTIONP01HL057346 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 1997 to 2013
$19.9M
Regulation of Factor VIII SecretionR01HL052173 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 1995 to 2014
$6.5M
Role of the Unfolded Protein Response in Beta CellR37DK042394 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2007 to 2016
$4.9M
Regulation of ER stress-induced cell deathR01DK088227 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2010 to 2014
$3.1M
Unfolded Protein Response in Glucose HomeostasisR01DK042394 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2003 to 2006
$1.2M
TRANSLATIONAL CONTROL IN REGULATION OF APOPTOSISR01AI042394 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 1998 to 2002
$675k
Alteration in protein interactions with proinsulin and insulin in type 2 diabetesR24DK093074 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KAUFMAN, RANDAL J. · 2011 to 2011
$518k
NHLBI NIH HHS HL052173NHLBI NIH HHS HL057346NHLBI NIH HHS P01 HL057346NHLBI NIH HHS R01 HL052173NIAID NIH HHS R01 AI042394NIDDK NIH HHS DK042394NIDDK NIH HHS DK093074NIDDK NIH HHS DK88227NIDDK NIH HHS R01 DK042394NIDDK NIH HHS R01 DK088227NIDDK NIH HHS R24 DK093074NIDDK NIH HHS R37 DK042394
6 · The paper itself

Abstract

Given the functional importance of the endoplasmic reticulum (ER), an organelle that performs folding, modification, and trafficking of secretory and membrane proteins to the Golgi compartment, the maintenance of ER homeostasis in insulin-secreting β-cells is very important. When ER homeostasis is disrupted, the ER generates adaptive signaling pathways, called the unfolded protein response (UPR), to maintain homeostasis of this organelle. However, if homeostasis fails to be restored, the ER initiates death signaling pathways. New observations suggest that both chronic hyperglycemia and hyperlipidemia, known as important causative factors of type 2 diabetes (T2D), disrupt ER homeostasis to induce unresolvable UPR activation and β-cell death. This review examines how the UPR pathways, induced by high glucose and free fatty acids (FFAs), interact to disrupt ER function and cause β-cell dysfunction and death.

Indexed as

Endoplasmic Reticulum StressAnimalsDiabetes Mellitus, Type 2HumansInsulin-Secreting CellsSignal TransductionUnfolded Protein Response

Identifiers

PMID22443930
PMCPMC3684428
OpenAlexW2165266278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.